256 related articles for article (PubMed ID: 25162218)
1. Comparison of everolimus QMS immunoassay on Architect ci4100 and liquid chromatography/mass spectrometry: lack of agreement in organ-transplanted patients.
Hoffer E; Kurnik D; Efrati E; Scherb I; Karasik M; Ring G; Bentur Y
Ther Drug Monit; 2015 Apr; 37(2):214-9. PubMed ID: 25162218
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of QMS everolimus assay using Indiko analyzer: comparison with an ultra-performance liquid chromatography-tandem mass spectrometry method.
Buthiau D; Bargnoux AS; Badiou S; Sutra T; Dupuy AM; Pageaux GP; Mourad G; Cristol JP
Ther Drug Monit; 2015 Apr; 37(2):275-8. PubMed ID: 25254414
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic Drug Monitoring of Everolimus: Comparability of Concentrations Determined by 2 Immunoassays and a Liquid Chromatography Tandem Mass Spectrometry Method.
Shipkova M; Rapp S; Rigo-Bonnin R; Wieland E; Peter A
Ther Drug Monit; 2017 Apr; 39(2):102-108. PubMed ID: 28125504
[TBL] [Abstract][Full Text] [Related]
4. Analytical performance of QMS everolimus assay on ortho Vitros 5,1 FS fusion analyzer: measuring everolimus trough levels for solid organ transplant recipients.
Shu I; Wright AM; Chandler WL; Bernard DW; Wang P
Ther Drug Monit; 2014 Apr; 36(2):264-8. PubMed ID: 24232125
[TBL] [Abstract][Full Text] [Related]
5. Long-term cross-validation of everolimus therapeutic drug monitoring assays: the Zortracker study.
Schniedewind B; Niederlechner S; Galinkin JL; Johnson-Davis KL; Christians U; Meyer EJ
Ther Drug Monit; 2015 Jun; 37(3):296-303. PubMed ID: 25970506
[TBL] [Abstract][Full Text] [Related]
6. Everolimus method comparison between Waters MassTrak™ Immunosuppressants XE (IUO) kit and an in-house laboratory developed LC-MS/MS method in renal transplant patients.
Johnson-Davis KL; Juenke JM; Thomas RL; Bradshaw T
Ann Clin Lab Sci; 2015; 45(1):27-31. PubMed ID: 25696007
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of QMS everolimus assay using Hitachi 917 Analyzer: comparison with liquid chromatography/mass spectrometry.
Dasgupta A; Davis B; Chow L
Ther Drug Monit; 2011 Apr; 33(2):149-54. PubMed ID: 21266941
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the Abbott ARCHITECT i2000 sirolimus assay and comparison with the Abbott IMx sirolimus assay and an established liquid chromatography-tandem mass spectrometry method.
Johnson-Davis KL; De S; Jimenez E; McMillin GA; De BK
Ther Drug Monit; 2011 Aug; 33(4):453-9. PubMed ID: 21743377
[TBL] [Abstract][Full Text] [Related]
9. Liquid chromatography-tandem mass spectrometry outperforms fluorescence polarization immunoassay in monitoring everolimus therapy in renal transplantation.
Moes DJ; Press RR; de Fijter JW; Guchelaar HJ; den Hartigh J
Ther Drug Monit; 2010 Aug; 32(4):413-9. PubMed ID: 20535052
[TBL] [Abstract][Full Text] [Related]
10. Multicenter Evaluation of a New Electrochemiluminescence Immunoassay for Everolimus Concentrations in Whole Blood.
Verstraete AG; Rigo-Bonnin R; Wallemacq P; Vogeser M; Schuetzenmeister A; Schmiedel C; Shipkova M
Ther Drug Monit; 2018 Feb; 40(1):59-68. PubMed ID: 29210975
[TBL] [Abstract][Full Text] [Related]
11. Analytical performance of a new liquid chromatography/tandem mass spectrometric method for determination of everolimus concentrations in whole blood.
McMillin GA; Johnson-Davis K; Dasgupta A
Ther Drug Monit; 2012 Apr; 34(2):222-6. PubMed ID: 22322402
[TBL] [Abstract][Full Text] [Related]
12. Low plasma concentrations of albumin influence the affinity column-mediated immunoassay method for the measurement of tacrolimus in blood during the early period after liver transplantation.
Tempestilli M; Di Stasio E; Basile MR; Elisei F; Antonini M; Ettorre GM; Iappelli M; Pucillo LP
Ther Drug Monit; 2013 Feb; 35(1):96-100. PubMed ID: 23191996
[TBL] [Abstract][Full Text] [Related]
13. Comparison of a stable isotope-labeled and an analog internal standard for the quantification of everolimus by a liquid chromatography-tandem mass spectrometry method.
Heideloff C; Payto D; Wang S
Ther Drug Monit; 2013 Apr; 35(2):246-50. PubMed ID: 23503452
[TBL] [Abstract][Full Text] [Related]
14. Immunosuppressive drugs in whole blood: validation of a commercially available liquid chromatography/tandem mass spectrometry kit and comparison with immunochemical assays.
Polledri E; Mercadante R; Ferraris Fusarini C; Maiavacca R; Fustinoni S
Rapid Commun Mass Spectrom; 2017 Jul; 31(13):1111-1120. PubMed ID: 28439923
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the everolimus concentrations measured in whole blood with everolimus QMS or sirolimus CMIA.
Capone D; Cataldi M; Guida B; Mosca T; Tarantino G
Scand J Clin Lab Invest; 2018 Jul; 78(4):275-280. PubMed ID: 29575933
[TBL] [Abstract][Full Text] [Related]
16. Everolimus TDM using Thermo Fisher QMS immunoassay on Indiko, Beckman DxC, AU680, and AU5800 analyzers.
Wong SH; Johnson-Davis KL; Garrison K; Rankin JD; Muhammad CS
Clin Biochem; 2017 May; 50(7-8):425-430. PubMed ID: 27988326
[TBL] [Abstract][Full Text] [Related]
17. Possibilities and limitations of signal summing for an immunosuppressant LC-MS/MS method.
Pauwels S; Jans I; Peersman N; Billen J; Vanderschueren D; Desmet K; Vermeersch P
Anal Bioanal Chem; 2015 Aug; 407(20):6191-9. PubMed ID: 26072209
[TBL] [Abstract][Full Text] [Related]
18. Two rapid ultra performance liquid chromatography/tandem mass spectrometry (UPLC/MS/MS) methods with common sample pretreatment for therapeutic drug monitoring of immunosuppressants compared to immunoassay.
Tszyrsznic W; Borowiec A; Pawlowska E; Jazwiec R; Zochowska D; Bartlomiejczyk I; Zegarska J; Paczek L; Dadlez M
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Jun; 928():9-15. PubMed ID: 23584041
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the Waters MassTrak LC-MS/MS Assay for Tacrolimus and a Comparison to the Abbott Architect Immunoassay.
Saitman A; Metushi IG; Mason DS; Fitzgerald RL
Ther Drug Monit; 2016 Jun; 38(3):300-4. PubMed ID: 26473523
[TBL] [Abstract][Full Text] [Related]
20. Robust, high-throughput LC-MS/MS method for therapeutic drug monitoring of cyclosporine, tacrolimus, everolimus, and sirolimus in whole blood.
Koster RA; Dijkers EC; Uges DR
Ther Drug Monit; 2009 Feb; 31(1):116-25. PubMed ID: 19065123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
